The field of gene editing has seen remarkable advancements over the past decade, with CRISPR-Cas9 technology leading the way. CRISPR Therapeutics (CRSP), one of the foremost players in this space, has made significant strides in applying this groundbreaking technology to develop gene-based treatments for serious diseases. The company’s lead therapy, CASGEVY (exagamglogene autotemcel or exa-cel), […]